Focal delivery of AAV2/1-transgenes into the rat brain by localized ultrasound-induced BBB opening

Molecular Therapy Nucleic Acids

Volumn 2, Issue , 2013, Pages e73-

  Alonso, Angelika ^a   Reinz, Eileen ^b   Leuchs, Barbara ^b   Kleinschmidt, Jürgen ^b   Fatar, Marc ^a   Geers, Bart ^c   Lentacker, Ine ^c   Hennerici, Michael G ^a   De Smedt, Stefaan C ^c   Meairs, Stephen ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

AAV; Blood brain barrier; Ultrasound

Indexed keywords

BETA GALACTOSIDASE;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; GLIA CELL; IMMUNOFLUORESCENCE; IN VIVO GENE TRANSFER; MACROMOLECULE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENE; ULTRASOUND;

EID: 84878848911     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2012.64     Document Type: Article

References (37)

1. Meairs, S and Alonso, A (2007). Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol 93: 354-362. (Pubitemid 44809396)
2. Pardridge, WM (2005). The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2: 3-14. (Pubitemid 40128022)
3. Alonso, A, Reinz, E, Fatar, M, Jenne, J, Hennerici, MG and Meairs, S (2010). Neurons but not glial cells overexpress ubiquitin in the rat brain following focused ultrasound-induced opening of the blood-brain barrier. Neuroscience 169: 116-124.
4. Alonso, A, Reinz, E, Fatar, M, Hennerici, MG and Meairs, S (2011). Clearance of albumin following ultrasound-induced blood-brain barrier opening is mediated by glial but not neuronal cells. Brain Res 1411: 9-16.
5. Hynynen, K, McDannold, N, Vykhodtseva, N and Jolesz, FA (2001). Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220: 640-646. (Pubitemid 32799969)
6. Samiotaki, G, Vlachos, F, Tung, YS and Konofagou, EE (2012). A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI. Magn Reson Med 67: 769-777.
7. Sheikov, N, McDannold, N, Sharma, S and Hynynen, K (2008). Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 34: 1093-1104. (Pubitemid 351893156)
8. Deng, J, Huang, Q, Wang, F, Liu, Y, Wang, Z, Wang, Z et al. (2012). The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles. J Mol Neurosci 46: 677-687.
9. Treat, LH, McDannold, N, Vykhodtseva, N, Zhang, Y, Tam, K and Hynynen, K (2007). Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121: 901-907. (Pubitemid 47106223)
10. Huang, Q, Deng, J, Wang, F, Chen, S, Liu, Y, Wang, Z et al. (2012). Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Exp Neurol 233: 350-356.
11. LeWitt, PA, Rezai, AR, Leehey, MA, Ojemann, SG, Flaherty, AW, Eskandar, EN et al. (2011). AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial. Lancet Neurol 10: 309-319.
12. Mandel, RJ (2010). CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer's disease. Curr Opin Mol Ther 12: 240-247.
13. McCown, TJ (2011). Adeno-Associated Virus (AAV) Vectors in the CNS. Curr Gene Ther 11: 181-188.
14. Tenenbaum, L, Chtarto, A, Lehtonen, E, Velu, T, Brotchi, J and Levivier, M (2004). Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med 6 Suppl 1: S212-S222. (Pubitemid 40228030)
15. Mastakov, MY, Baer, K, Symes, CW, Leichtlein, CB, Kotin, RM and During, MJ (2002). Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain. J Virol 76: 8446-8454. (Pubitemid 34809096)
16. McCown, TJ, Xiao, X, Li, J, Breese, GR and Samulski, RJ (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713: 99-107. (Pubitemid 26114833)
17. Davidson, BL, Stein, CS, Heth, JA, Martins, I, Kotin, RM, Derksen, TA et al. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 97: 3428-3432. (Pubitemid 30183319)
18. Chao, H, Liu, Y, Rabinowitz, J, Li, C, Samulski, RJ and Walsh, CE (2000). Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2: 619-623.
19. Burger, C, Gorbatyuk, OS, Velardo, MJ, Peden, CS, Williams, P, Zolotukhin, S et al. (2004). Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 10: 302-317. (Pubitemid 39117875)
20. Foust, KD, Nurre, E, Montgomery, CL, Hernandez, A, Chan, CM and Kaspar, BK (2009). Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27: 59-65.
21. Gray, SJ, Matagne, V, Bachaboina, L, Yadav, S, Ojeda, SR and Samulski, RJ (2011). Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19: 1058-1069.
22. Vasileva, A and Jessberger, R (2005). Precise hit: adeno-associated virus in gene targeting. Nat Rev Microbiol 3: 837-847. (Pubitemid 41693179)
23. Kügler, S, Lingor, P, Schöll, U, Zolotukhin, S and Bähr, M (2003). Differential transgene expression in brain cells in vivo and in vitro from AAV-2 vectors with small transcriptional control units. Virology 311: 89-95. (Pubitemid 36794213)
24. Konofagou, EE, Tung, YS, Choi, J, Deffieux, T, Baseri, B and Vlachos, F (2012). Ultrasound-induced blood-brain barrier opening. Curr Pharm Biotechnol 13: 1332-1345.
25. Liu, HL, Yang, HW, Hua, MY and Wei, KC (2012). Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status. Neurosurg Focus 32: E4.
26. McDannold, N, Vykhodtseva, N, Raymond, S, Jolesz, FA and Hynynen, K (2005). MRIguided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 31: 1527-1537. (Pubitemid 41606266)
27. Bartlett, JS, Wilcher, R and Samulski, RJ (2000). Infectious entry pathway of adenoassociated virus and adeno-associated virus vectors. J Virol 74: 2777-2785. (Pubitemid 30117589)
28. Meijering, BD, Juffermans, LJ, van Wamel, A, Henning, RH, Zuhorn, IS, Emmer, M et al. (2009). Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 104: 679-687.
29. Geers, B, Lentacker, I, Alonso, A, Sanders, NN, Demeester, J, Meairs, S et al. (2011). Elucidating the mechanisms behind sonoporation with adeno-associated virus-loaded microbubbles. Mol Pharm 8: 2244-2251.
30. Gray, SJ, Foti, SB, Schwartz, JW, Bachaboina, L, Taylor-Blake, B, Coleman, J et al. (2011). Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum Gene Ther 22: 1143-1153.
31. Paterna, JC, Moccetti, T, Mura, A, Feldon, J and Büeler, H (2000). Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther 7: 1304-1311. (Pubitemid 30623777)
32. Müller, OJ, Kaul, F, Weitzman, MD, Pasqualini, R, Arap, W, Kleinschmidt, JA et al. (2003). Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 21: 1040-1046. (Pubitemid 37064733)
33. Varadi, K, Michelfelder, S, Korff, T, Hecker, M, Trepel, M, Katus, HA et al. (2012). Novel random peptide libraries displayed on AAV serotype 9 for selection of endothelial celldirected gene transfer vectors. Gene Ther 19: 800-809.
34. Grimm, D (2002). Production methods for gene transfer vectors based on adenoassociated virus serotypes. Methods 28: 146-157. (Pubitemid 35341078)
35. Zolotukhin, S, Potter, M, Hauswirth, WW, Guy, J and Muzyczka, N (1996). A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J Virol 70: 4646-4654.
36. Grimm, D, Kay, MA and Kleinschmidt, JA (2003). Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 7: 839-850. (Pubitemid 36790261)
37. Alonso, A, Reinz, E, Jenne, JW, Fatar, M, Schmidt-Glenewinkel, H, Hennerici, MG et al. (2010). Reorganization of gap junctions after focused ultrasound blood-brain barrier opening in the rat brain. J Cereb Blood Flow Metab 30: 1394-1402.